Saint-Petersburg State Medical University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00678418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Saint-Petersburg State Medical University n.a. Pavlov | Saint Petersburg State University, Russia | Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of High Medical Technologies | St. Petersburg State Medical University n.a. I.P.Pavlov

Active Ingredients

Drugs in Phase 4 Trials (1)

lidocaine (xylocaine) (1 trial)

Drugs in Phase 3 Trials (2)

naltrexone (revia) (1 trial)

teriparatide (1 trial)

Drugs in Phase 2 Trials (5)

arginine (1 trial)

dabrafenib (tafinlar) (1 trial)

lenvatinib (lenvima) (1 trial)

pembrolizumab (keytruda) (1 trial)

trametinib (mekinist) (1 trial)

Drugs in Other Trials (1)

tadalafil (cialis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 4)

Opioid-Related Disorders (Phase 3)

Parathyroid Neoplasms (Phase 4)

Peripheral Arterial Disease (Phase 2)

Peripheral Vascular Diseases (Phase 2)

Thyroid Diseases (Phase 4)

Thyroid Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 9